E-drug: Workshop: Strengthening medicine supply in National Tuberculosis Programs: Practical Guidelines and Tools
-------------------------------------------
[Very short notice! KM]
Management Sciences for Health's Rational Pharmaceutical Management Plus
(RPM plus) program in collaboration with the Stop TB's Global TB Drug
Facility (GDF) has the pleasure to announce a day long workshop at the
36th Union World Conference on Lung Disease (The UNION) in Paris,
France.
Venue: Le Palais des Congres de Paris, Room 362/363
Title: Strengthening medicine supply in National Tuberculosis Programs:
Practical Guidelines and Tools
Description: Strong pharmaceutical management is one of the key pillars
to effective tuberculosis (TB) control; without appropriate selection,
effective procurement, distribution, stock management and rational use
of TB medicines and related supplies, individuals will not be cured of
the disease and countries will not reach global targets. Interventions
to strengthen TB pharmaceutical management are most effective if guided
by informed decision-making. This workshop seeks to introduce specific
tools to effectively gauge the current situation in TB drug supply and
to share with participants how other TB programs use these tools and
practical solutions gained from the tools to strengthen their supply
systems. The tools used by the GDF in providing quality TB medicines to
national TB programs and in identifying needs for technical assistance
in pharmaceutical management will be an integral part of the sessions.
Target audience: Managers of NTPs, managers of essential medicines and
procurement departments, medicines policy makers, and TB
donors/partners, including consultants who conduct program assessments
on behalf of the GDF.
Objectives:
* To share tools and practical solutions used by other countries
in strengthening TB pharmaceutical management (activities, processes,
indicators, self evaluations, implications for interventions,
interventions employed, monitoring techniques and outcomes of
interventions to date)
* To allow participants to practice use of tools for quantifying
and monitoring TB medicines procured through the GDF
* To share information on how to access technical assistance for
pharmaceutical management.
Expected outcome: Participants will have a deeper understanding on how
to analyze the current situation and how to apply practical solutions
for strengthening product selection, procurement, distribution, stock
management and rational use by national TB programs. Participants will
become familiar with the tools available to quantify and monitor TB
medicines procured through the GDF and on how to access technical
assistance for unresolved problems in pharmaceutical management.
Speakers:
Margareth Dalcomo MDR-TB Center/Brazil
Joel Keravec MSH/Brazil TB Pharmaceutical Management
Lai Yuji China NTP/CDC
Hugo Vrakking WHO/Global TB Drug Facility
Helene Castel WHO/Global TB Drug Facility
Robert Matiru WHO/Global TB Drug Facility
Adam Thomas WHO/Global TB Drug Facility
Thomas Moore MSH TB Pharmaceutical Management
Andrey Zagorskiy MSH TB Pharmaceutical Management
Edgar Barillas MSH TB Pharmaceutical Management
Chinwe Owunna MSH TB Pharmaceutical Management
contact info: mjimenez@msh.org
http://www.msh.org/projects/rpmplus/3.5.htm